down arrow

STAAR Surgical Co.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US8523123052
  • NASDAQ: STAA
USD
19.80
-0.85 (-4.12%)

Sep 23

NAS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
LivaNova Plc
STAAR Surgical Co.
AtriCure, Inc.
iRhythm Technologies, Inc.
ICU Medical, Inc.
Integer Holdings Corp.
CONMED Corp.
Axonics, Inc.
Integra LifeSciences Holdings Corp.
InMode Ltd.
Pacific Biosciences of California, Inc.

Why is STAAR Surgical Co. ?

1
With a growth in Net Sales of 111.04%, the company declared Outstanding results in Jun 26
  • The company has declared positive results for the last 2 consecutive quarters
  • NET SALES(Q) At USD 93.53 MM has Grown at 111.04%
  • PRE-TAX PROFIT(Q) At USD 11.02 MM has Grown at 153.34%
  • NET PROFIT(Q) At USD 8.06 MM has Grown at 169.68%
2
With ROE of -14.82%, it has a risky valuation with a 2.57 Price to Book Value
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -25.42%, its profits have fallen by -152.4%
3
Rising Promoter Confidence
  • Promoters have increased their stake in the company by 8.59% over the previous quarter and currently hold 39.03% of the company
  • Promoters increasing their stake is a sign of high confidence in the future of the business
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to STAAR Surgical Co. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is STAAR Surgical Co. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
STAAR Surgical Co.
-25.42%
-0.84
57.42%
S&P 500
15.76%
1.20
13.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
7.93%
EBIT Growth (5y)
-244.24%
EBIT to Interest (avg)
8.83
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.63
Sales to Capital Employed (avg)
0.76
Tax Ratio
15.90%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
22.61%
ROE (avg)
5.89%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.57
EV to EBIT
-14.51
EV to EBITDA
-17.56
EV to Capital Employed
4.33
EV to Sales
2.94
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-29.85%
ROE (Latest)
-14.82%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

28What is working for the Company
NET SALES(Q)

At USD 93.53 MM has Grown at 111.04%

PRE-TAX PROFIT(Q)

At USD 11.02 MM has Grown at 153.34%

NET PROFIT(Q)

At USD 8.06 MM has Grown at 169.68%

RAW MATERIAL COST(Y)

Fallen by -0.98% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 4.88 times

-2What is not working for the Company
DEBT-EQUITY RATIO (HY)

Highest at -39.83 %

Here's what is working for STAAR Surgical Co.

Net Sales
At USD 93.53 MM has Grown at 111.04%
Year on Year (YoY)
MOJO Watch
Near term sales trend is extremely positive

Net Sales (USD MM)

Pre-Tax Profit
At USD 11.02 MM has Grown at 153.34%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Net Profit
At USD 8.06 MM has Grown at 169.68%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (USD MM)

Debtors Turnover Ratio
Highest at 4.88 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -0.98% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at USD 3.34 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Depreciation
At USD 3.34 MM has Grown at 51.02%
period on period (QoQ)
MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (USD MM)

Here's what is not working for STAAR Surgical Co.

Debt-Equity Ratio
Highest at -39.83 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Footer loading